JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.07B |
| 2 |
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
|
+$1.82B |
| 3 |
AT&T
T
|
+$779M |
| 4 |
Gilead Sciences
GILD
|
+$774M |
| 5 |
Eli Lilly
LLY
|
+$590M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$1.06B |
| 2 |
MON
Monsanto Co
MON
|
+$890M |
| 3 |
CVS Health
CVS
|
+$779M |
| 4 |
SLB Ltd
SLB
|
+$600M |
| 5 |
Chevron
CVX
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.33% |
| 2 | Healthcare | 12.01% |
| 3 | Technology | 10.9% |
| 4 | Consumer Discretionary | 8.31% |
| 5 | Industrials | 7.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRTY
2526
DELISTED
Party City Holdco Inc.
PRTY
| $3.08M | ﹤0.01% |
+152,050
| New | +$3.24M |
|
|
ISEE
2527
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $3.08M | ﹤0.01% |
59,089
+19,764
| +50% | +$983K |
|
2528
Independent Bank
INDB
$3.99B
| $3.08M | ﹤0.01% |
65,612
-608
| -0.9% | -$27.1K |
|
2529
CALL
Applied Materials
AMAT
$403B
| $3.08M | ﹤0.01% |
160,000
-2,126,900
| -93% | -$43.7M |
|
2530
8x8 Inc
EGHT
$269M
| $3.07M | ﹤0.01% |
342,700
-23,090
| -6% | -$204K |
|
2531
iShares Core MSCI Emerging Markets ETF
IEMG
$150B
| $3.05M | ﹤0.01% |
63,479
-18,688
| -23% | -$946K |
|
2532
Cboe Global Markets
CBOE
$32.5B
| $3.05M | ﹤0.01% |
53,280
+22,708
| +74% | +$1.31M |
|
|
AMRI
2533
DELISTED
Albany Molecular Research Inc
AMRI
| $3.03M | ﹤0.01% |
149,833
+44,683
| +42% | +$862K |
|
|
KNL
2534
DELISTED
Knoll, Inc.
KNL
| $3.03M | ﹤0.01% |
121,012
-114,229
| -49% | -$2.69M |
|
|
REV
2535
DELISTED
Revlon, Inc.
REV
| $3.02M | ﹤0.01% |
82,123
-4,000
| -5% | -$152K |
|
2536
FIVE9
FIVN
$2.11B
| $3.01M | ﹤0.01% |
+575,800
| New | +$3.16M |
|
|
NXGN
2537
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $3.01M | ﹤0.01% |
181,420
+8,700
| +5% | +$140K |
|
|
PLKI
2538
PUT
DELISTED
Popeyes Louisiana Kitchen, Inc.
PLKI
| $3M | ﹤0.01% |
50,000
| – | – |
|
2539
Photronics
PLAB
$1.79B
| $3M | ﹤0.01% |
315,250
-12,659
| -4% | -$119K |
|
2540
Sun Communities
SUI
$15.2B
| $3M | ﹤0.01% |
48,441
-1,241
| -2% | -$78.6K |
|
|
LOXO
2541
DELISTED
Loxo Oncology, Inc
LOXO
| $2.99M | ﹤0.01% |
+166,000
| New | +$2.27M |
|
|
GPT
2542
DELISTED
Gramercy Property Trust
GPT
| $2.97M | ﹤0.01% |
42,411
+2,609
| +7% | +$209K |
|
2543
Tanger
SKT
$4.67B
| $2.97M | ﹤0.01% |
93,636
+12,049
| +15% | +$408K |
|
|
XOMA
2544
DELISTED
Xoma
XOMA
| $2.96M | ﹤0.01% |
38,196
-328
| -0.9% | -$23.6K |
|
2545
IMAX
IMAX
$2.62B
| $2.96M | ﹤0.01% |
73,493
-217
| -0.3% | -$8.43K |
|
|
HYLD
2546
DELISTED
High Yield ETF
HYLD
| $2.96M | ﹤0.01% |
+72,800
| New | +$3.02M |
|
2547
PUT
Cleveland-Cliffs
CLF
$6.57B
| $2.95M | ﹤0.01% |
680,800
-251,500
| -27% | -$1.34M |
|
2548
Aegon
AEG
$14B
| $2.95M | ﹤0.01% |
566,201
+225,319
| +66% | +$1.22M |
|
2549
Schwab International Equity ETF
SCHF
$66.6B
| $2.94M | ﹤0.01% |
193,270
+53,896
| +39% | +$846K |
|
2550
CALL
Lam Research
LRCX
$367B
| $2.94M | ﹤0.01% |
361,000
-139,000
| -28% | -$1.09M |
|
Similar funds
JP Morgan Chase's Q2 2015 Portfolio in Review
As of Q2 2015, JP Morgan Chase held 4,397 positions worth $424B, down 3.4% from $439B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2015 filing shows 356 new, 1,656 increased, 1,613 reduced and 411 closed positions. Its largest new stake was Fitbit, Inc. Class A common stock: 1,923,189 shares worth $73.5M. The largest sale was Johnson & Johnson, an estimated $1.06B.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Technology.
- JP Morgan Chase's largest Q2 2015 buy was Fitbit, Inc. Class A common stock: 1,923,189 shares worth $73.5M.
- JP Morgan Chase added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $2.07B increase.
- JP Morgan Chase's biggest Q2 2015 reduction was Johnson & Johnson, cutting an estimated $1.06B.
- JP Morgan Chase fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $342M.
- JP Morgan Chase's ten largest holdings make up 17% of its $424B portfolio in Q2 2015.
- JP Morgan Chase opened 356 new positions and closed 411 in Q2 2015.
- JP Morgan Chase's portfolio value fell 3.4% quarter-over-quarter to $424B.
Based on JP Morgan Chase's 13F filing for Q2 2015, filed 14 Aug 2015.